Almunda Professionals (AMUND) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
1 Oct, 2026Executive summary
Net revenue increased 57% year-over-year to €20.5 million for H1 2026, but the period ended with a net loss of €1.7 million attributable to shareholders.
Operating profit (EBIT) was negative at -€1.7 million, reflecting underperformance in the Healthcare Professionals segment and one-off costs.
Utility Professionals segment performed well, generating positive cash flows and margins, while PIDZ (Healthcare) faced significant challenges.
Financial highlights
Net revenue: €20.5 million (H1 2026) vs. €13.1 million (H1 2025).
EBITDA: €91 thousand (H1 2026) vs. €1.7 million (H1 2025).
Net result per share: -€0.07 (H1 2026) vs. -€0.03 (H1 2025).
Net cash position: €2.2 million (30 June 2026) vs. €3.1 million (30 June 2025).
Total equity: €10.9 million (30 June 2026) vs. €13.7 million (30 June 2025).
Outlook and guidance
Management expects adequate resources to continue operations, supported by financing agreements and shareholder backing.
Structural improvements at Novisource are expected to support future profitability.
Latest events from Almunda Professionals
- Revenue up 8% to €31.4m; stable EBITDA; net loss €0.58m; positive 2026 outlook.AMUND
H2 2025 - Revenue and EBITDA fell, with a net loss; ICE segment remains strong amid market headwinds.AMUND
H1 2025 - Revenue up 20% to €14.6m, but profit outlook cautious amid tougher market.AMUND
H1 2024 - Revenue up, net result down; PIDZ pivots, ICE grows, Novisource restructures.AMUND
H2 2024